According to preliminary and unaudited data, sales of OssDsign Catalyst amounted to
"The continued strong market performance of OssDsign Catalyst means we have already exceeded market expectations after only two months in the quarter and confirms the attractiveness of our recently announced strategy shift to fully focus on the high-margin orthobiologics franchise", said
A complete financial statement for the fourth quarter will be presented in the year-end report for 2023, to be published on
This disclosure contains information that
CEO
+46 18 55 39 93
morten.henneveld@ossdsign.com
https://news.cision.com/ossdsign-ab/r/ossdsign-s-revenues-for-the-fourth-quarter-of-2023-are-expected-to-exceed-market-estimates,c3888332
https://mb.cision.com/Main/18020/3888332/2474758.pdf
(c) 2023 Cision. All rights reserved., source